IDT Corporation's latest moves, explained simply — so you know why the numbers change.
Straight from SEC filings · updated 6 Aug 2026New board members with pharmaceutical experience help guide company decisions and oversee finances.
Quarterly reports let investors track if the company is growing or shrinking over time.
Earnings announcements reveal how much money the company made and spent each quarter.
Dividends are profits returned to shareholders; higher dividends can reward patient investors.
Quarterly reports let investors track if the company is growing or shrinking over time.
Earnings announcements reveal how much money the company made and spent each quarter.
Stocky reads IDT Corporation's official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.
IDT Corporation's most recent tracked filing was a 8-K on 11 Jun 2026: William Conkling joins board as independent director.
No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.
Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 6 Aug 2026.